3 general anethesia
DESCRIPTION
TRANSCRIPT
1
General Anesthetics
Jieyu FangThe First Affiliated Hospital
房洁渝
中山大学附属第一医院
2
Principles of General Anesthesia
Minimizing the potentially harmful direct and indirect effects of anesthetic agents and techniques
Sustaining physiologic homeostasis during surgical procedures
Improving post-operative outcomes
3
4
What are General Anesthetics?
Drugs that bring about a reversible loss of consciousness.
These drugs are generally administered by an anesthesiologist in order to induce or maintain general anesthesia to facilitate surgery.
5
Background
General anesthesia was absent until the mid-1800’s
William Morton administered ether to a patient having a neck tumor removed at the Massachusetts General Hospital, Boston, in October 1846.
The discovery of the diethyl ether as general anesthesia was the result of a search for means of eliminating a patient’s pain perception and responses to painful stimuli.
6
Anesthetics divide into 2 classes:
Inhalation Anesthetics
Gasses or Vapors Usually
Halogenated
Intravenous Anesthetics
InjectionsAnesthetics or induction agents
7
Hypotheses of General Anesthesia
1. Lipid Theory: based on the fact that anesthetic action is correlated with the oil/gas coefficients.
The higher the solubility of anesthetics is in oil, the greater is the anesthetic potency.
Meyer and Overton Correlations Irrelevant
8
Other Theories included
2. Protein (Receptor) Theory: based on the fact that anesthetic potency is correlated with the ability of anesthetics to inhibit enzymes activity of a protein. The GABAA receptor is a potential target of anesthetics action.
GABA: γ-aminobutyric acid synapseNMDA receptor: N-methyl-D-aspartate
3.Binding theory: Anesthetics bind to hydrophobic portion of the ion
channel
9
GABA receptors gamma-aminobutyric acid
The GABA receptors are a class of receptors that respond to the neurotransmitter gamma-aminobutyric acid (GABA), the chief inhibitory neurotransmitter in the central nervous system.
two classes of GABA rec: GABAA and GABAB.
GABAA receptors are ligand-gated ion channels, Its
endogenous ligand is γ-aminobutyric acid (GABA), the major inhibitory neurotransmitter in the central nervous system.
GABAB receptors are G protein-coupled receptors.
10
GABA receptors
Upon activation, the GABAA receptor
selectively conducts Cl- through its pore, resulting in hyperpolarization of the neuron. This causes an inhibitory effect on neurotransmission by diminishing the chance of a successful action potential occurring.
11
NMDA receptor
The NMDA (N-methyl D-aspartate) receptor, is for controlling synaptic plasticity and memory function.
Activation of NMDA receptors results in the opening of an ion channel . NMDA receptor is voltage-dependent activation, a result of ion channel block by extracellular Mg2+ ions. This allows voltage-dependent flow of Na+ and small amounts of Ca2+ ions into the cell and K+ out of the cell.
Calcium flux through NMDARs is thought to play a critical role in synaptic plasticity, a cellular mechanism for learning and memory.
The NMDA receptor is distinct in two ways: First, it is both ligand-gated and voltage-dependent; second, it requires co-activation by two ligands - glutamate and glycine.
12
Mechanism of Action
UNKNOWN!! Most Recent Studies:
General Anesthetics acts on the CNS by modifying the electrical activity of neurons at a molecular level by modifying functions of ION CHANNELS.
This may occur by anesthetic molecules binding directly to ion channels or by their disrupting the functions of molecules that maintain ion channels.
13
Mechanism
Scientists have cloned forms of receptors in the past decades, adding greatly to knowledge of the proteins involved in neuronal excitability. These include: Voltage-gated ion channels, such as sodium,
potassium, and calcium channels Ligand-gated ion channel superfamily and G protein-coupled receptors superfamily.
14
Intravenous Anesthetics
Barbiturates – thiopental (Pentothal) 硫喷妥钠 methohexital (Brevital) thiamylal (Surital)
propofol (Diprivan) 丙泊酚 Ketamine 氯胺酮 Benzodiazepines
midazolam (Versed) 咪达唑仑 diazepam (Valium) 地西泮 lorazepam (Ativan)
etomidate (Amidate) 依托咪酯
15
Pharmacology of intravenous (IV) anesthetics
IV anesthetics are commonly used for induction of general anesthesia, maintenance of GA, and sedation during local or regional anesthesia.
The rapid onset and offset of these drugs are due to their physical translocation in and out of the brain. After a bolus IV injection, fat-soluble drugs like propofol, thiopental, and etomidate rapidly distribute into highly perfused tissues like brain and heart, causing an extremely rapid onset of effect.
16
Pharmacology of intravenous (IV) anesthetics
Plasma conc ↓ rapidly as the drugs continue to be distributed into muscle and fat. When plasma conc have decreased sufficiently, these drugs rapidly redistribute out of the brain, and their effects are terminated.
17
Pharmacology of intravenous (IV) anesthetics
Active drug remains in the body, so clearance still needs to occur, typically by hepatic metabolism and renal elimination.
18
Elimination half-time is defined as the time required for the plasma concentration of drug to decrease by 50% during the terminal (elimination) phase of clearance
Context-sensitive half-time (CSHT) is defined as the time for a 50% decrease in the central compartment drug concentration after an infusion of specified duration.
19
Propofol
Propofol (2,6-diisopropylphenol) is used for induction or maintenance of general anesthesia as well as for conscious sedation. It is prepared as a 1% isotonic oil-in-water emulsion, which contains egg lecithin, glycerol, and soybean oil.
20
21
propofol
Mode of action: Increases activity at inhibitory GABA synapses. Inhibition of glutamate (N-methyl-D-aspartate [NMDA]) receptors may play a role.
Pharmacokinetics Hepatic (and some extrahepatic)
metabolism to inactive metabolites. The CSHT of propofol (see Fig. 11.1) is 15
min after a 2-hour infusion.
22
propofol
Pharmacodynamics Central nervous system (CNS)
Induction doses produce unconscious Induction doses produce unconscious (30 to 45 seconds), followed by rapid reawakening due to redistribution
Low doses produce sedationLow doses produce sedation. Weak analgesic effects
Raises seizure threshold. Decreases intracranial pressure (ICP) but also
cerebral perfusion pressure..
23
Properties of Intravenous Anesthetic Agents-propofol
Cardiovascular system Cardiovascular depressantCardiovascular depressant Dose-
dependent decrease in preload and afterload and depression of heart contractility leading to decreases in arterial pressure and cardiac output.
Heart rate is minimally affected, and baroreceptor reflex is blunted.
#
24
Dosages of commonly used IV anesthetics
Respiratory system Produces a dose-dependent decrease in respiratory
rate and tidal volume. Ventilatory response to hypercarbia is diminished.#
Dosage and administration: Table 11.1.
Induction dose: 2~2.5 mg/kg
Maintenance infusion Titrate with reduced doses in elderly or hemodynamically
compromised patients
Discard propofol opened more than 6 hours : Propofol
emulsion supports bacterial growth; prevent bacterial
contamination.
25
Monitor.jpg
26
propofol
Other effects Venous irritation : Injection pain during IV
administration reduced by adding lidocaine
antiemetic effects : Less postoperative
nausea and vomiting
Lipid disorders Myoclonus Propofol infusion syndrome :a rare and fatal disorder
that occurs in critically ill patients (usually children) subjected to prolonged, high-dose propofol infusions. Typical features include rhabdomyolysis, metabolic acidosis, cardiac failure, and renal failure
Some abuse potential.
27
Benzodiazepines
midazolam Diazepam lorazepam
They are often used for sedation and amnesia or as adjuncts to general anesthesia.
Midazolam is prepared in a water-soluble form at pH 3.5, while diazepam and lorazepam are dissolved in propylene glycol and polyethylene glycol, respectively.
28
Benzodiazepines
Mode of action: Enhance the inhibitory tone of GABA receptors.
Pharmacokinetics IV , the onset of CNS effects occurs in 2 to 3
minutes for midazolam and diazepam. metabolized in the liver. Elimination half-lives
for midazolam, lorazepam, and diazepam are approximately 2, 11, and 20 hours. The active metabolites of diazepam last longer than the parent drug.
Diazepam clearance is reduced in the elderly, but this is less of a problem with midazolam and lorazepam.
29
Benzodiazepines
Pharmacodynamics CNS
Produce amnestic, anticonvulsant, anxiolytic, muscle-relaxant, and sedative-hypnotic effects in a dose-dependent manner. Amnesia may last only 1 hour after a single premedicant dose of midazolam. Sedation may sometimes be prolonged.#anterograde amnesia
no analgesia.# Reduce cerebral blood flow and metabolic
rate.
30
Benzodiazepines
Cardiovascular systema mild systemic vasodilation and reduction
in cardiac output. Heart rate unchanged.
Respiratory systemProduce a mild dose-dependent decrease
in respiratory rate and tidal volume.Respiratory depression may be
pronounced if administered with an opioid, in patients with pulmonary disease, or in debilitated patients.
31
Benzodiazepines
Dosage and administration: See Table 11.1 midalozam iv 0.1-0.4mg/kg
IV diazepam 2.5 mg IV lorazepam 0.25 mg for sedation. orally diazepam 5 to 10 mg orally lorazepam 2 to 4 mg of.
32
Benzodiazepines
Adverse effects Drug interactions. a benzodiazepine to
anticonvulsant valproate may precipitate a psychotic episode.
Pregnancy and labor associated with birth defects (cleft lip and palate)
when administered during the first trimester. Cross the placenta and may lead to a depressed
neonate. Superficial thrombophlebitis and injection pain
diazepam and lorazepam.
33
Flumazenil
Flumazenil is a competitive antagonist for benzodiazepine receptors in the CNS. Reversal of benzodiazepine-induced sedative
effects occurs within 2 min. Flumazenil is shorter acting than the
benzodiazepines. Repeated administration may be necessary.
Metabolized in the liver. Flumazenil is contraindicated in patients with
tricyclic antidepressant overdose and in those receiving benzodiazepines for control of seizures or elevated intracranial pressure.
34
Ketamine
Ketamine is a sedative-hypnotic agent with powerful analgesic properties. Usually used as an induction agent.
Mode of action: Not well defined, antagonism at the NMDA receptor.
Pharmacokinetics unconsciousness in 30 to 60 s after an IV dose. Effects are
terminated by redistribution in 15 to 20 min. After intramuscular (IM) administration, the onset of CNS effects is 5 min, with peak effect at approximately 15 min.
Metabolized rapidly in the liver. Elimination half-life = 2 to 3 hours.
Repeated bolus doses or an infusion results in accumulation.
35
Ketamine
Pharmacodynamics CNS
Produces a “dissociative” state accompanied by amnesia and analgesia. Analgesic effects persist after awakening.
Increases cerebral blood flow (CBF), metabolic rate, and intracranial pressure. #CBF response to hyperventilation is not blocked.
#
36
Ketamine
Cardiovascular system ↑HR ↑, BP , centrally mediated release of
endogenous catecholamines. Often used to induce general anesthesia in
hemodynamically compromised patients.
Respiratory system depresses RR and tidal volume mildly Alleviates bronchospasm by a sympathomimetic
effect. Laryngeal protective reflexes are relatively well-
maintained.
37
Ketamine
Dosage and administration: See Table 11.1. IM / IV, IM in whom IV access is not available (e.g.,
children).
Adverse effects Oral secretions stimulated antisialagogue (glycopyrrolate,atropine) be helpful. Emotional disturbance. # 1)cause restlessness and agitation; hallucinations
and unpleasant dreams. 2) Risk factors :age, female gender, and dosage. 3) reduced with benzodiazepine (e.g., midazolam)
or propofol. Children seem to be less troubled. Alternatives to ketamine should be considered in patients with psychiatric disorders.
38
Ketamine
Muscle tone ↑. random myoclonic movements.
Increases intracranial pressure and is relatively contraindicated in patients with head trauma or intracranial hypertension.
Ocular effects. May lead to mydriasis, nystagmus, diplopia, blepharospasm, and increased intraocular pressure; alternatives should be considered during ophthalmologic surgery.
Anesthetic depth may be difficult to assess..
39
Etomidate
Etomidate is an imidazole-containing hypnotic unrelated to other anesthetics.
It is most commonly used as an IV induction agent for general anesthesia.
Mode of action: Augments the inhibitory tone of GABA in the CNS.
Pharmacokinetics clearance in the liver and by circulating esterases to
inactive metabolites. Times to loss of consciousness and awakening
similar to propofol.
40
Etomidate
Pharmacodynamics CNS
No analgesic Cerebral blood flow, metabolism, and ICP
decrease while cerebral perfusion pressure is usually maintained.
Cardiovascular system. minimal changes in HR, BP, CO. Does not affect sympathetic tone or baroreceptor function, not suppress hemodynamic responses to pain. often chosen to induce general anesthesia in hemodynamically compromised patients.
Respiratory system. decrease in RR, tidal volume; transient apnea may occur.
41
Etomidate
Dosage and administration: IV, See Table 11.1. Adverse effects
Myoclonus after administration Nausea and vomiting more frequently than other
anesthetics Venous irritation and superficial
thrombophlebitis Adrenal suppression. A single dose suppresses
adrenal steroid synthesis for up to 24 hours (probably an effect of little clinical significance). Repeated doses or infusions are not recommended because of the risk of significant adrenal suppression.
42
Properties of Intravenous Anesthetic Agents
Drug Induction and Recovery
Main Unwanted Effects
Notes
thiopental Fast onset (accumulation occurs, giving slow recovery) Hangover
Cardiovascular and respiratory depression
Used as induction agent declining. ↓ CBF and O2 consumption
Injection pain
etomidate Fast onset, fairly fast recovery
Excitatory effects during induction Adrenocortical suppression
Less cvs and resp depression than with thiopental, Injection site pain
propofol Fast onset, very fast recovery
cvs and resp depression
Pain at injection site.
Most common induction agent. Rapidly metabolized; possible to use as continuous infusion. Injection pain. Antiemetic
ketamine Slow onset, after-effects common during recovery
Psychotomimetic effects following recovery, Postop nausea, vomiting , salivation
Produces good analgesia and amnesia. No injection site pain
midazolam Slower onset than other agents
Minimal CV and resp effects.
Little resp or cvs depression. No pain. Good amnesia.
43
Non-barbiturate induction drugs effects on BP and HR
Drug Systemic BP
Heart Rate
propofol ↓ ↓
etomidate No change or slight ↓
No change
ketamine ↑ ↑
44
45
Opioids Morphine meperidine hydromorphone fentanyl sufentanil alfentanil remifentanil opioids used in GA.
★ primary effect : analgesia ★ to supplement other agents during induction or maintenance of GA. In high doses, opioids are used as the sole anesthetic (e.g., cardiac
surgery).
46
Opioids
Mode of action: Opioids bind at specific receptors in the brain, spinal cord, and on peripheral neurons. The opioids are selective for μopioid receptors.
Pharmacokinetics The CSHTs for alfentanil, sufentanil, and remifentanil are shown in
p19 Elimination is primarily by the liver. Remifentanil is metabolized by
circulating and skeletal muscle esterases. Morphine and meperidine have important active metabolites; hydromorphone and the fentanyl derivatives do not. The metabolites are primarily excreted in the urine.
IV, onset of action is within minutes for the fentanyl derivatives; hydromorphone and morphine may take 20 to 30 minutes for peak effect..
47
Opioids
Pharmacodynamics CNS
Produce sedation and analgesia in a dose-dependent manner; euphoria is common , not reliable hypnotics.
Reduce the minimum alveolar concentration (MAC) of volatile and gaseous anesthetic agents, and reduce the requirements for IV sedative-hypnotic drugs.
Decrease CBF and metabolic rate.
48
Opioids
Cardiovascular system minimal changes in cardiac
contractility , except meperidine. reduce SVR , meperidine or morphine
( histamine release ) bradycardia. Meperidine has a weak atropine-like
effect. Hemodynamic stable
49
Opioids
Respiratory system◆Produce respiratory depression in a dose-
dependent manner. accentuated sedatives, other respiratory depressants, pulmonary disease. ◆ Decrease ventilatory response to hypercapnia and hypoxia. ◆ Decrease the cough reflex , endotracheal tubes are better tolerated.
Pupil size is decreased (miosis) by stimulation of the Edinger-Westphal nucleus of the oculomotor nerve.
50
Opioids
Muscle rigidity in the chest, abdomen, and upper airway, inability to ventilate.
* may be reversed by neuromuscular relaxants or opioid antagonists.
* pretreatment with benzodiazepine or propofol. Gastrointestinal system
decrease in gastric emptying. Colonic tone and sphincter tone increase, and propulsive contractions decrease
Increase biliary pressure and may produce biliary colic Nausea and vomiting can occur because of direct stimulation
of the chemoreceptor trigger zone.
51
Opioids
Urinary retention Allergic reactions are rare, although anaphylactoid
(histamine) reactions are seen with morphine and meperidine.
Drug interactions. Administration of meperidine to a patient who has received a monoamine oxidase inhibitor may result in delirium or hyperthermia and may be fatal.
52
Opioids
Dosage and administration.
IV, either by bolus or infusion.
Larger doses may be required in patients chronically receiving opioids.
53
Naloxone
Naloxone is a pure opioid antagonist used to reverse unanticipated or undesired opioid-induced effects such as respiratory or CNS depression. Mode of action. a competitive antagonist at opioid
receptors in the brain and spinal cord. Pharmacokinetics
Peak effects within 1 to 2 min; a decrease in its clinical effects occurs after 30 min because of redistribution. repeated
Metabolized in the liver. Pharmacodynamics
Reverses opioids CNS and respiratory depression. Crosses the placenta.
54
Naloxone
Dosage and administration: 0.04 mg IV every 2 to 3 min as needed.
Adverse effects Pain. abrupt pain as opioid analgesia is
reversed. ( hypertension, tachycardia). Cardiac arrest. in rare cases, pulmonary
edema and cardiac arrest. Repeated administration may be
necessary because of its short duration of action.
55
Pharmacology of inhalation anesthetics
Inhalation anesthetics are usually administered for maintenance of general anesthesia but also can be used for induction, especially in pediatric patients.
56
minimum alveolar concentration
MAC, minimum alveolar concentration at one atmosphere at which 50% of patients do not move in response to a surgical stimulus. MAC best correlates inversely with lipid/gas
partition coefficient (the greater the lipid solubility the lower the MAC)
最低肺泡有效浓度 ( MAC )1atm 下同时吸入麻醉药和氧, 50% 病人在切皮
时无体动的最低肺泡浓度;MAC 愈小,麻醉效能愈强 ,1.3MAC
57
MAC and Lipid Solubility
Agent Lipid/Gas Coefficient
MAC
halothane 224 0.76
enflurane 98 1.68
ether 65 1.90
sevoflurane 53 1.85
nitrous oxide 1.4 105
58
inhalation anesthetics
Mode of action Nitrous oxide. not clear interaction with cellular membranes of the CNS Volatile anesthetics. unknown Various ion channels in the CNS (including
GABA, glycine, and NMDA receptors) have been shown to be sensitive to inhalation anesthetics and may play a role.
59
inhalation anesthetics
Pharmacokinetics Nitrous oxide
Uptake and elimination of nitrous oxide are rapid compared with other inhaled anesthetics, low blood-gas partition coefficient (0.47).
Nitrous oxide is eliminated via exhalation.
60
Uptake, Distribution and Elimination of Anesthetic Gases, p29
Agent Blood/Gas (λ) MAC Rapidity of Onset
N2O 0.47 104 1
sevoflurane 0.69 2.05 2
Isoflurane 1.4 1.15 3
enflurane 1.9 1.68 4
halothane 2.3 0.74 5
ethyl ether 12.1 6
61
inhalation anesthetics
Volatile anesthetics Determinants of speed of onset and offset. FA : alveolar anesthetic concentrationFI: inspired anesthetic concentration . The rate of rise of the ratio
of these two concentrations (FA/FI) determines the speed of induction of general anesthesia
Blood-gas partition coefficient. A lower solubility in blood will lead to lower uptake of anesthetic into the bloodstream, thereby increasing the rate of rise of FA/FI.
Inspired anesthetic concentration, which is influenced by circuit size, fresh gas inflow rate, and absorption of volatile anesthetic by circuit components. Alveolar ventilation. Increased minute ventilation. Concentration effect.
62
inhalation anesthetics
The second gas effect. When nitrous oxide and a potent inhalation anesthetic are administered together, the uptake of nitrous oxide concentrates the “second” gas (e.g., isoflurane) and increases the input of additional second gas into alveoli via augmentation of inspired volume.
Cardiac output. An increase in cardiac output will increase anesthetic uptake
Gradient between alveolar and venous blood.
63
inhalation anesthetics
Distribution in tissues. The rate of equilibration of anesthetic partial pressure between blood and a particular organ system depends on the following factors: Tissue blood flow. Equilibration occurs more
rapidly in tissues receiving increased perfusion. The most highly perfused organ include the brain, kidney, heart, liver, and endocrine glands.
Tissue solubility. anesthetic agents with high tissue solubility are slower to equilibrate. Blood-brain partition coefficients of inhalation agents are shown in Table 11.3.
Gradient between arterial blood and tissue.
64
inhalation anesthetics
Elimination Exhalation. This is the predominant route of
elimination. Metabolism. Volatile anesthetics may undergo
different degrees of hepatic metabolism, the effect is not clinically significant.
Anesthetic loss. Inhalation anesthetics may be lost both percutaneously and through visceral membranes, negligible.
65
Figure 11.2. Ratio of alveolar to inspired gas concentration (FA/FI)
as a function of time at constant cardiac output and minute ventilation.
66
Nitrous oxide
Pharmacodynamics Nitrous oxide
CNS Produces analgesia. Conc greater than 60% may produce amnesia, not
reliable. high MAC (104%), usually combined with other
anesthetics to attain surgical anesthesia. Cardiovascular system
Mild myocardial depressant and a mild sympathetic nervous system stimulant.
HR,BP unchanged Respiratory system. a mild respiratory depressant
67
Volatile anesthetics
CNS Produce unconsciousness and amnesia at low
inspired concentrations (25% MAC). Produce a dose-dependent generalized CNS
depression Produce decreased somatosensory evoked potentials. Increase CBF (halothane > enflurane > isoflurane,
desflurane, or sevoflurane). Decrease cerebral metabolic rate (isoflurane,
desflurane, or sevoflurane > enflurane > halothane). Uncouple autoregulation of CBF
68
Volatile anesthetics
Cardiovascular system Produce dose-dependent myocardial depression
and systemic vasodilation
Heart rate unchanged. Sensitize the myocardium to the arrhythmogenic
effects of catecholamines (halothane > enflurane > isoflurane or desflurane > sevoflurane), particularly during infiltration of epinephrine-containing solutions or administration of sympathomimetic agents.
patients with coronary artery disease, isoflurane may redirect coronary flow away from ischemic areas.
69
Volatile anesthetics
Respiratory system Produce dose-dependent respiratory
depression. Produce airway irritation (desflurane >
isoflurane > enflurane > halothane > sevoflurane) and, during light levels of anesthesia, may precipitate coughing, laryngospasm, or bronchospasm.#
volatile agents possess similar bronchodilator effects, with the exception of desflurane, which has mild bronchoconstricting activity.
70
Volatile anesthetics
Muscular system decrease in muscle tone, enhancing surgical
conditions. May precipitate malignant hyperthermia
Liver. May cause a decrease in hepatic perfusion (halothane > enflurane > isoflurane, desflurane, or sevoflurane). “halothane hepatitis”
Renal system. Decrease renal blood flow
71
Volatile anesthetics
Problems related to specific agents Nitrous oxide
Expansion of closed gas spaces. Spaces containing air such as a pneumothorax, occluded middle ear, bowel lumen, or pneumocephalus will markedly enlarge if nitrous oxide is administered. Nitrous oxide will diffuse into the cuff of an endotracheal tube and may increase pressure within the cuff.
72
Nitrous oxide
Diffusion hypoxia. After discontinuation of nitrous oxide, its rapid diffusion from the blood into the lung may lead to a low partial pressure of oxygen in the alveoli, resulting in hypoxia and hypoxemia if supplemental oxygen is not administered. Continue supply O2 after discontinuation of N2O for 10 min.
Inhibition of tetrahydrofolate synthesis. Nitrous oxide should be used with caution in pregnant patients and those deficient in vitamin B12.
73
Nitrous oxide
Nitrous oxide, known as happy gas or laughing gas, due to the euphoric effects
Nitrous oxide is a weak anesthetic, not used alone in GA. It is used as a carrier gas in a 2:1 ratio with oxygen for more powerful general anesthetic agents such as sevoflurane or desflurane.
never receives 100% nitrous. Instead you breath a mix of nitrous and oxygen -- generally 70% N2O to 30% oxygen. This is equivalent to the amount of oxygen in room air -- but the nitrogen has been replaced by nitrous oxide. #
unless administered with at least 20 percent oxygen, hypoxia can be induced.
Nitrous oxide does not kill brain cells, but lack of oxygen does
74
Desflurane
Desflurane can be degraded to carbon monoxide in carbon dioxide absorbents (especially Baralyme).
a few cases of clinically significant carbon monoxide poisoning have been reported.
75
Sevoflurane
Sevoflurane can be degraded in CO2 absorbents (especially Baralyme) to fluoromethyl-2,2,-difluoro-1-vinyl ether (Compound A), which has been shown to produce renal toxicity in animal models.
Compound A concentrations increase at low fresh gas rates. There has been no evidence of consistent renal toxicity with sevoflurane usage in humans.
76
Enflurane
Enflurane can produce electroencephalographic epilepti-form activity at high inspired concentrations (>2%).
77
Inhalation Anesthetic Agents
Anesthetic gases – only one is Nitrous Oxide Volatile liquids
halothane (Fluothane) – inexpensive, good bronchodilator
isoflurane (Forane) – commonly for adults, inexpensive
enflurane (Ethrane) – like isoflurane, except increased risk of seizures. Rarely used
desflurane (Suprane) – similar to isoflurane except for more rapid emergence, and more irritating to airway
sevoflurane (Ultane) – similar to desflurane except not irritating to airway, one of the best!!
78
Halothane Isoflurane Desflurane sevoflurane
Alveolar equilibration
Slow Moderate Fast Fast
Recovery Slow Moderate Very fast Fast
Hepatotoxic Yes No No No
Metabolism 12 – 25% 0.2% 0.02% 3 – 6%
Muscle relax Moderate Significant Significant Significant
Heart rate Reduced Increased Increased Stable
Cardiac output
Reduced Slightly reduced
Stable Slightly reduced
Respir irritation
No Significant Significant No
Respir depression
Yes Yes Marked yes
79
Summary
propofol : cvs depress
thiopental Ketamine : analgesic, ↑HR , BP , CBF, Emotional disturbance ,
im Benzodiazepines- Flumazenil
Long t1/2, anticonvulsion , mild m. relax
midazolam diazepam lorazepam
Etomidate- Less Less CVS depress, CVS depress, aged group, Adrenocortical suppress, 1 dose
OPIOID- Naloxone
80
Elimination half-time Context-sensitive half-time (CSHT) :
infusion 时 - 量相关半衰期
MAC
81
82
83
84
85
86
87
88
89
90
Overview of Discussion
Historical Perspective What is General Anesthesia?
Definition Principles of Surgical Anesthesia
Hemodynamic and Respiratory Effects Hypothermia Nausea and Vomiting Emergence
Mechanisms of Anesthesia Early Ideas Cellular Mechanisms Structures
Molecular Actions: GABAA Receptor Mechanism of Propofol (Diprivan®)
Metabolism and Toxicity Adverse Affects of Propofol Remaining Questions Concerning the GABAA Receptor Latest Discoveries and Current Events
91
Historical Perspective
Original discoverer of general anesthetics Crawford Long: 1842,
ether anesthesia
Chloroform introduced James Simpson: 1847
Nitrous oxide Horace Wells
19th Century physician administering chloroform
92
Definition of General Anesthesia
Reversible, drug-induced loss of consciousness Depresses the nervous system
Anesthetic state Collection of component changes in behavior or
perception Amnesia, immobility in response to stimulation,
attenuation of autonomic responses to painful stimuli, analgesia, and unconsciousness
93
The Body and General Anesthesia
Hemodynamic effects: decrease in systemic arterial blood pressure
Respiratory effects: reduce or eliminate both ventilatory drive and reflexes maintaining the airway unblocked
Hypothermia: body temperature < 36˚C Nausea and Vomiting
Chemoreceptor trigger zone
Emergence Physiological changes
94
Mechanism
Early Ideas Unitary theory of anesthesia
Anesthesia is produced by disturbance of the physical properties of cell membranes
Problematic: theory fails to explain how the proposed disturbance of the lipid bilayer would result in a dysfunctional membrane protein
Inhalational and intravenous anesthetics can be enantio-selective in their action
Focus on identifying specific protein binding sites for anesthetics
95
Cellular Mechanism
Intravenous Anesthetics Substantial effect on synaptic transmission Smaller effect on action-potential generation or
propagation Produce narrower range of physiological effects
Actions occur at the synapse Effects the post-synaptic response to the
released neurotransmitter Enhances inhibitory neurotransmission
96
Structures
Intravenous
Inhalational
Propofol Etomidate Ketamine
Halothane Isoflurane Sevoflurane
97
Molecular Actions: GABAA Receptor
Ligand-gated ion channels Chloride channels gated by
the inhibitory GABAA receptor GABAA receptor mediates
the effects of gamma-amino butyric acid (GABA), the major inhibitory neurotransmitter in the brain
GABAA receptor found throughout the CNS
Most abundant, fast inhibitory, ligand-gated ion channel in the mammalian brain
Located in the post-synaptic membrane
98
Molecular Actions: GABAA Receptor
GABAA receptor is a 4-transmembrane (4-TM) ion channel 5 subunits arranged around a central pore:
2 alpha, 2 beta, 1 gamma Each subunit has N-terminal extracellular chain which
contains the ligand-binding site 4 hydrophobic sections cross the membrane 4 times:
one extracellular and two intracellular loops connecting these regions, plus an extracellular C-terminal chain
99
Molecular Action: GABAA Receptor
100
Molecular Action: GABAA Receptor
Receptor sits in the membrane of its neuron at the synapse
GABA, endogenous compound, causes GABA to open
Receptor capable of binding 2 GABA molecules, between an alpha and beta subunit Binding of GABA causes a
conformational change in receptor
Opens central pore Chloride ions pass down
electrochemical gradient Net inhibitory effect, reducing
activity of the neuron
101
Mechanism of Propofol
Action of anesthetics on the GABAA receptor Binding of anesthetics to specific sites on the
receptor protein Proof of this mechanism is through point
mutations Can eliminate the effects of the anesthetic on ion
channel function
General anesthetics do not compete with GABA for its binding on the receptor
102
Mechanism of Propofol
Inhibits the response to painful stimuli by interacting with beta3 subunit of GABAA
receptor Sedative effects of Propofol mediated by the
same GABAA receptor on the beta2 subunit Indicates that two components of anesthesia
can be mediated by GABAA receptor Action of Propofol
Positive modulation of inhibitory function of GABA through GABAA receptors
103
Mechanism of Propofol
Parenteral anesthetic Small, hydrophobic, substituted aromatic or
heterocyclic compound Propofol partitions into lipophilic tissues of
the brain and spinal cord Produces anesthesia within a single circulation
time
104
Metabolism and Toxicity
Recovery after doses/infusion of Propofol is fast
Half-life is “context-sensitive” Based on its own hydrophobicity and metabolic
clearance, Propofol’s half-life is 1.8 hours Accounts for the quick 2-4 minute distribution to
the entire body Expected for a highly lipid-soluble drug
Anesthetic of choice
105
Adverse Effects of Propofol
Hypotension Arrhythmia Myocardial ischemia
Restriction of blood supply
Confusion Rash Hyper-salivation Apnea
106
107
Latest Discoveries: Implications for the Medicinal Chemist
Explosion of new information on the structure and function of GABAA receptors Cloning and sequencing multiple subunits
Advantageous: large number of different subunits (16) allows for a great variety of different types of GABAA receptors that will likely differ in drug sensitivity
Propofol delivery technology Mechanically driven pumps Computer-controlled infusion systems
“target controlled infusion” (TCI)
108
Inhaled Anesthetics
Halothane Enflurane Isoflurane Desflurane
Halogenated compounds:
Contain Fluorine and/or bromide
Simple, small molecules